nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphotericin B—Cardiac failure—Capecitabine—esophageal cancer	0.00218	0.00218	CcSEcCtD
Amphotericin B—Stomatitis—Cisplatin—esophageal cancer	0.00217	0.00217	CcSEcCtD
Amphotericin B—Conjunctivitis—Cisplatin—esophageal cancer	0.00217	0.00217	CcSEcCtD
Amphotericin B—Hyponatraemia—Capecitabine—esophageal cancer	0.00214	0.00214	CcSEcCtD
Amphotericin B—Melaena—Methotrexate—esophageal cancer	0.00214	0.00214	CcSEcCtD
Amphotericin B—Pain in extremity—Capecitabine—esophageal cancer	0.00213	0.00213	CcSEcCtD
Amphotericin B—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00213	0.00213	CcSEcCtD
Amphotericin B—Diplopia—Capecitabine—esophageal cancer	0.00213	0.00213	CcSEcCtD
Amphotericin B—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00211	0.00211	CcSEcCtD
Amphotericin B—Skin exfoliation—Methotrexate—esophageal cancer	0.00209	0.00209	CcSEcCtD
Amphotericin B—Face oedema—Capecitabine—esophageal cancer	0.00206	0.00206	CcSEcCtD
Amphotericin B—Bradycardia—Cisplatin—esophageal cancer	0.00204	0.00204	CcSEcCtD
Amphotericin B—Cardiac arrest—Capecitabine—esophageal cancer	0.00203	0.00203	CcSEcCtD
Amphotericin B—Urinary retention—Capecitabine—esophageal cancer	0.00203	0.00203	CcSEcCtD
Amphotericin B—Coma—Methotrexate—esophageal cancer	0.002	0.002	CcSEcCtD
Amphotericin B—Blood creatinine increased—Capecitabine—esophageal cancer	0.002	0.002	CcSEcCtD
Amphotericin B—Dehydration—Capecitabine—esophageal cancer	0.00198	0.00198	CcSEcCtD
Amphotericin B—Mouth ulceration—Methotrexate—esophageal cancer	0.00198	0.00198	CcSEcCtD
Amphotericin B—Ecchymosis—Methotrexate—esophageal cancer	0.00198	0.00198	CcSEcCtD
Amphotericin B—Urinary tract disorder—Cisplatin—esophageal cancer	0.00198	0.00198	CcSEcCtD
Amphotericin B—Liver function test abnormal—Capecitabine—esophageal cancer	0.00197	0.00197	CcSEcCtD
Amphotericin B—Connective tissue disorder—Cisplatin—esophageal cancer	0.00197	0.00197	CcSEcCtD
Amphotericin B—Urethral disorder—Cisplatin—esophageal cancer	0.00196	0.00196	CcSEcCtD
Amphotericin B—Dry skin—Capecitabine—esophageal cancer	0.00195	0.00195	CcSEcCtD
Amphotericin B—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00195	0.00195	CcSEcCtD
Amphotericin B—Abdominal pain upper—Capecitabine—esophageal cancer	0.00195	0.00195	CcSEcCtD
Amphotericin B—Pulmonary oedema—Methotrexate—esophageal cancer	0.00195	0.00195	CcSEcCtD
Amphotericin B—Hypokalaemia—Capecitabine—esophageal cancer	0.00194	0.00194	CcSEcCtD
Amphotericin B—Visual impairment—Cisplatin—esophageal cancer	0.00193	0.00193	CcSEcCtD
Amphotericin B—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00192	0.00192	CcSEcCtD
Amphotericin B—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00192	0.00192	CcSEcCtD
Amphotericin B—Sepsis—Methotrexate—esophageal cancer	0.0019	0.0019	CcSEcCtD
Amphotericin B—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00188	0.00188	CcSEcCtD
Amphotericin B—Tinnitus—Cisplatin—esophageal cancer	0.00187	0.00187	CcSEcCtD
Amphotericin B—Flushing—Cisplatin—esophageal cancer	0.00186	0.00186	CcSEcCtD
Amphotericin B—Abdominal distension—Capecitabine—esophageal cancer	0.00186	0.00186	CcSEcCtD
Amphotericin B—Asthma—Capecitabine—esophageal cancer	0.00184	0.00184	CcSEcCtD
Amphotericin B—Dysphagia—Capecitabine—esophageal cancer	0.00184	0.00184	CcSEcCtD
Amphotericin B—Thrombophlebitis—Methotrexate—esophageal cancer	0.00183	0.00183	CcSEcCtD
Amphotericin B—Bronchospasm—Capecitabine—esophageal cancer	0.00181	0.00181	CcSEcCtD
Amphotericin B—Immune system disorder—Cisplatin—esophageal cancer	0.00181	0.00181	CcSEcCtD
Amphotericin B—Sweating increased—Capecitabine—esophageal cancer	0.00179	0.00179	CcSEcCtD
Amphotericin B—Arrhythmia—Cisplatin—esophageal cancer	0.00179	0.00179	CcSEcCtD
Amphotericin B—Alopecia—Cisplatin—esophageal cancer	0.00177	0.00177	CcSEcCtD
Amphotericin B—Abdominal discomfort—Capecitabine—esophageal cancer	0.00177	0.00177	CcSEcCtD
Amphotericin B—Hepatic failure—Methotrexate—esophageal cancer	0.00177	0.00177	CcSEcCtD
Amphotericin B—Erythema—Cisplatin—esophageal cancer	0.00174	0.00174	CcSEcCtD
Amphotericin B—Malnutrition—Cisplatin—esophageal cancer	0.00174	0.00174	CcSEcCtD
Amphotericin B—Dysuria—Capecitabine—esophageal cancer	0.00172	0.00172	CcSEcCtD
Amphotericin B—Renal failure acute—Methotrexate—esophageal cancer	0.00172	0.00172	CcSEcCtD
Amphotericin B—Flatulence—Cisplatin—esophageal cancer	0.00172	0.00172	CcSEcCtD
Amphotericin B—Weight increased—Capecitabine—esophageal cancer	0.00168	0.00168	CcSEcCtD
Amphotericin B—Muscle spasms—Cisplatin—esophageal cancer	0.00167	0.00167	CcSEcCtD
Amphotericin B—Weight decreased—Capecitabine—esophageal cancer	0.00167	0.00167	CcSEcCtD
Amphotericin B—Hyperglycaemia—Capecitabine—esophageal cancer	0.00166	0.00166	CcSEcCtD
Amphotericin B—Pneumonia—Capecitabine—esophageal cancer	0.00165	0.00165	CcSEcCtD
Amphotericin B—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00164	0.00164	CcSEcCtD
Amphotericin B—Tremor—Cisplatin—esophageal cancer	0.00163	0.00163	CcSEcCtD
Amphotericin B—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00163	0.00163	CcSEcCtD
Amphotericin B—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00162	0.00162	CcSEcCtD
Amphotericin B—Ill-defined disorder—Cisplatin—esophageal cancer	0.00162	0.00162	CcSEcCtD
Amphotericin B—Renal failure—Capecitabine—esophageal cancer	0.00162	0.00162	CcSEcCtD
Amphotericin B—Myocardial infarction—Capecitabine—esophageal cancer	0.00161	0.00161	CcSEcCtD
Amphotericin B—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00161	0.00161	CcSEcCtD
Amphotericin B—Anaemia—Cisplatin—esophageal cancer	0.00161	0.00161	CcSEcCtD
Amphotericin B—Stomatitis—Capecitabine—esophageal cancer	0.0016	0.0016	CcSEcCtD
Amphotericin B—Jaundice—Capecitabine—esophageal cancer	0.0016	0.0016	CcSEcCtD
Amphotericin B—Conjunctivitis—Capecitabine—esophageal cancer	0.0016	0.0016	CcSEcCtD
Amphotericin B—Malaise—Cisplatin—esophageal cancer	0.00157	0.00157	CcSEcCtD
Amphotericin B—Haematuria—Capecitabine—esophageal cancer	0.00157	0.00157	CcSEcCtD
Amphotericin B—Leukopenia—Cisplatin—esophageal cancer	0.00156	0.00156	CcSEcCtD
Amphotericin B—Epistaxis—Capecitabine—esophageal cancer	0.00155	0.00155	CcSEcCtD
Amphotericin B—Agranulocytosis—Capecitabine—esophageal cancer	0.00153	0.00153	CcSEcCtD
Amphotericin B—Convulsion—Cisplatin—esophageal cancer	0.00151	0.00151	CcSEcCtD
Amphotericin B—Bradycardia—Capecitabine—esophageal cancer	0.0015	0.0015	CcSEcCtD
Amphotericin B—Myalgia—Cisplatin—esophageal cancer	0.00148	0.00148	CcSEcCtD
Amphotericin B—Haemoglobin—Capecitabine—esophageal cancer	0.00148	0.00148	CcSEcCtD
Amphotericin B—Rhinitis—Capecitabine—esophageal cancer	0.00148	0.00148	CcSEcCtD
Amphotericin B—Anxiety—Cisplatin—esophageal cancer	0.00148	0.00148	CcSEcCtD
Amphotericin B—Haemorrhage—Capecitabine—esophageal cancer	0.00147	0.00147	CcSEcCtD
Amphotericin B—Hepatitis—Capecitabine—esophageal cancer	0.00147	0.00147	CcSEcCtD
Amphotericin B—Liver function test abnormal—Methotrexate—esophageal cancer	0.00147	0.00147	CcSEcCtD
Amphotericin B—Discomfort—Cisplatin—esophageal cancer	0.00147	0.00147	CcSEcCtD
Amphotericin B—Pharyngitis—Capecitabine—esophageal cancer	0.00146	0.00146	CcSEcCtD
Amphotericin B—Urinary tract disorder—Capecitabine—esophageal cancer	0.00146	0.00146	CcSEcCtD
Amphotericin B—Oedema peripheral—Capecitabine—esophageal cancer	0.00145	0.00145	CcSEcCtD
Amphotericin B—Connective tissue disorder—Capecitabine—esophageal cancer	0.00145	0.00145	CcSEcCtD
Amphotericin B—Urethral disorder—Capecitabine—esophageal cancer	0.00145	0.00145	CcSEcCtD
Amphotericin B—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00143	0.00143	CcSEcCtD
Amphotericin B—Oedema—Cisplatin—esophageal cancer	0.00142	0.00142	CcSEcCtD
Amphotericin B—Anaphylactic shock—Cisplatin—esophageal cancer	0.00142	0.00142	CcSEcCtD
Amphotericin B—Visual impairment—Capecitabine—esophageal cancer	0.00142	0.00142	CcSEcCtD
Amphotericin B—Infection—Cisplatin—esophageal cancer	0.00141	0.00141	CcSEcCtD
Amphotericin B—Erythema multiforme—Capecitabine—esophageal cancer	0.00139	0.00139	CcSEcCtD
Amphotericin B—Thrombocytopenia—Cisplatin—esophageal cancer	0.00139	0.00139	CcSEcCtD
Amphotericin B—Tachycardia—Cisplatin—esophageal cancer	0.00139	0.00139	CcSEcCtD
Amphotericin B—Skin disorder—Cisplatin—esophageal cancer	0.00138	0.00138	CcSEcCtD
Amphotericin B—Tinnitus—Capecitabine—esophageal cancer	0.00138	0.00138	CcSEcCtD
Amphotericin B—Hyperhidrosis—Cisplatin—esophageal cancer	0.00137	0.00137	CcSEcCtD
Amphotericin B—Asthma—Methotrexate—esophageal cancer	0.00137	0.00137	CcSEcCtD
Amphotericin B—Flushing—Capecitabine—esophageal cancer	0.00137	0.00137	CcSEcCtD
Amphotericin B—Eosinophilia—Methotrexate—esophageal cancer	0.00136	0.00136	CcSEcCtD
Amphotericin B—Anorexia—Cisplatin—esophageal cancer	0.00136	0.00136	CcSEcCtD
Amphotericin B—Pancreatitis—Methotrexate—esophageal cancer	0.00134	0.00134	CcSEcCtD
Amphotericin B—Angiopathy—Capecitabine—esophageal cancer	0.00134	0.00134	CcSEcCtD
Amphotericin B—Immune system disorder—Capecitabine—esophageal cancer	0.00133	0.00133	CcSEcCtD
Amphotericin B—Hypotension—Cisplatin—esophageal cancer	0.00133	0.00133	CcSEcCtD
Amphotericin B—Chills—Capecitabine—esophageal cancer	0.00132	0.00132	CcSEcCtD
Amphotericin B—Arrhythmia—Capecitabine—esophageal cancer	0.00132	0.00132	CcSEcCtD
Amphotericin B—Abdominal discomfort—Methotrexate—esophageal cancer	0.00132	0.00132	CcSEcCtD
Amphotericin B—Alopecia—Capecitabine—esophageal cancer	0.0013	0.0013	CcSEcCtD
Amphotericin B—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.0013	0.0013	CcSEcCtD
Amphotericin B—Erythema—Capecitabine—esophageal cancer	0.00128	0.00128	CcSEcCtD
Amphotericin B—Malnutrition—Capecitabine—esophageal cancer	0.00128	0.00128	CcSEcCtD
Amphotericin B—Dysuria—Methotrexate—esophageal cancer	0.00128	0.00128	CcSEcCtD
Amphotericin B—Paraesthesia—Cisplatin—esophageal cancer	0.00128	0.00128	CcSEcCtD
Amphotericin B—Dyspnoea—Cisplatin—esophageal cancer	0.00127	0.00127	CcSEcCtD
Amphotericin B—Flatulence—Capecitabine—esophageal cancer	0.00127	0.00127	CcSEcCtD
Amphotericin B—Back pain—Capecitabine—esophageal cancer	0.00124	0.00124	CcSEcCtD
Amphotericin B—Decreased appetite—Cisplatin—esophageal cancer	0.00124	0.00124	CcSEcCtD
Amphotericin B—Muscle spasms—Capecitabine—esophageal cancer	0.00123	0.00123	CcSEcCtD
Amphotericin B—Pneumonia—Methotrexate—esophageal cancer	0.00123	0.00123	CcSEcCtD
Amphotericin B—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00123	0.00123	CcSEcCtD
Amphotericin B—Pain—Cisplatin—esophageal cancer	0.00122	0.00122	CcSEcCtD
Amphotericin B—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00121	0.00121	CcSEcCtD
Amphotericin B—Tremor—Capecitabine—esophageal cancer	0.0012	0.0012	CcSEcCtD
Amphotericin B—Renal failure—Methotrexate—esophageal cancer	0.0012	0.0012	CcSEcCtD
Amphotericin B—Stomatitis—Methotrexate—esophageal cancer	0.00119	0.00119	CcSEcCtD
Amphotericin B—Ill-defined disorder—Capecitabine—esophageal cancer	0.00119	0.00119	CcSEcCtD
Amphotericin B—Conjunctivitis—Methotrexate—esophageal cancer	0.00119	0.00119	CcSEcCtD
Amphotericin B—Anaemia—Capecitabine—esophageal cancer	0.00119	0.00119	CcSEcCtD
Amphotericin B—Sweating—Methotrexate—esophageal cancer	0.00117	0.00117	CcSEcCtD
Amphotericin B—Feeling abnormal—Cisplatin—esophageal cancer	0.00117	0.00117	CcSEcCtD
Amphotericin B—Haematuria—Methotrexate—esophageal cancer	0.00117	0.00117	CcSEcCtD
Amphotericin B—Malaise—Capecitabine—esophageal cancer	0.00116	0.00116	CcSEcCtD
Amphotericin B—Epistaxis—Methotrexate—esophageal cancer	0.00115	0.00115	CcSEcCtD
Amphotericin B—Vertigo—Capecitabine—esophageal cancer	0.00115	0.00115	CcSEcCtD
Amphotericin B—Syncope—Capecitabine—esophageal cancer	0.00115	0.00115	CcSEcCtD
Amphotericin B—Leukopenia—Capecitabine—esophageal cancer	0.00115	0.00115	CcSEcCtD
Amphotericin B—Agranulocytosis—Methotrexate—esophageal cancer	0.00114	0.00114	CcSEcCtD
Amphotericin B—Loss of consciousness—Capecitabine—esophageal cancer	0.00113	0.00113	CcSEcCtD
Amphotericin B—Body temperature increased—Cisplatin—esophageal cancer	0.00112	0.00112	CcSEcCtD
Amphotericin B—Cough—Capecitabine—esophageal cancer	0.00112	0.00112	CcSEcCtD
Amphotericin B—Hypertension—Capecitabine—esophageal cancer	0.00111	0.00111	CcSEcCtD
Amphotericin B—Haemoglobin—Methotrexate—esophageal cancer	0.0011	0.0011	CcSEcCtD
Amphotericin B—Haemorrhage—Methotrexate—esophageal cancer	0.0011	0.0011	CcSEcCtD
Amphotericin B—Hepatitis—Methotrexate—esophageal cancer	0.0011	0.0011	CcSEcCtD
Amphotericin B—Arthralgia—Capecitabine—esophageal cancer	0.00109	0.00109	CcSEcCtD
Amphotericin B—Myalgia—Capecitabine—esophageal cancer	0.00109	0.00109	CcSEcCtD
Amphotericin B—Chest pain—Capecitabine—esophageal cancer	0.00109	0.00109	CcSEcCtD
Amphotericin B—Pharyngitis—Methotrexate—esophageal cancer	0.00109	0.00109	CcSEcCtD
Amphotericin B—Anxiety—Capecitabine—esophageal cancer	0.00109	0.00109	CcSEcCtD
Amphotericin B—Urinary tract disorder—Methotrexate—esophageal cancer	0.00108	0.00108	CcSEcCtD
Amphotericin B—Discomfort—Capecitabine—esophageal cancer	0.00108	0.00108	CcSEcCtD
Amphotericin B—Urethral disorder—Methotrexate—esophageal cancer	0.00108	0.00108	CcSEcCtD
Amphotericin B—Dry mouth—Capecitabine—esophageal cancer	0.00107	0.00107	CcSEcCtD
Amphotericin B—Visual impairment—Methotrexate—esophageal cancer	0.00106	0.00106	CcSEcCtD
Amphotericin B—Confusional state—Capecitabine—esophageal cancer	0.00106	0.00106	CcSEcCtD
Amphotericin B—Oedema—Capecitabine—esophageal cancer	0.00105	0.00105	CcSEcCtD
Amphotericin B—Hypersensitivity—Cisplatin—esophageal cancer	0.00105	0.00105	CcSEcCtD
Amphotericin B—Infection—Capecitabine—esophageal cancer	0.00104	0.00104	CcSEcCtD
Amphotericin B—Erythema multiforme—Methotrexate—esophageal cancer	0.00104	0.00104	CcSEcCtD
Amphotericin B—Shock—Capecitabine—esophageal cancer	0.00103	0.00103	CcSEcCtD
Amphotericin B—Thrombocytopenia—Capecitabine—esophageal cancer	0.00103	0.00103	CcSEcCtD
Amphotericin B—Tinnitus—Methotrexate—esophageal cancer	0.00102	0.00102	CcSEcCtD
Amphotericin B—Tachycardia—Capecitabine—esophageal cancer	0.00102	0.00102	CcSEcCtD
Amphotericin B—Asthenia—Cisplatin—esophageal cancer	0.00102	0.00102	CcSEcCtD
Amphotericin B—Skin disorder—Capecitabine—esophageal cancer	0.00102	0.00102	CcSEcCtD
Amphotericin B—Hyperhidrosis—Capecitabine—esophageal cancer	0.00101	0.00101	CcSEcCtD
Amphotericin B—Anorexia—Capecitabine—esophageal cancer	0.000999	0.000999	CcSEcCtD
Amphotericin B—Angiopathy—Methotrexate—esophageal cancer	0.000996	0.000996	CcSEcCtD
Amphotericin B—Immune system disorder—Methotrexate—esophageal cancer	0.000992	0.000992	CcSEcCtD
Amphotericin B—Chills—Methotrexate—esophageal cancer	0.000985	0.000985	CcSEcCtD
Amphotericin B—Hypotension—Capecitabine—esophageal cancer	0.000979	0.000979	CcSEcCtD
Amphotericin B—Diarrhoea—Cisplatin—esophageal cancer	0.000973	0.000973	CcSEcCtD
Amphotericin B—Alopecia—Methotrexate—esophageal cancer	0.00097	0.00097	CcSEcCtD
Amphotericin B—Erythema—Methotrexate—esophageal cancer	0.000956	0.000956	CcSEcCtD
Amphotericin B—Malnutrition—Methotrexate—esophageal cancer	0.000956	0.000956	CcSEcCtD
Amphotericin B—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000955	0.000955	CcSEcCtD
Amphotericin B—Insomnia—Capecitabine—esophageal cancer	0.000948	0.000948	CcSEcCtD
Amphotericin B—Paraesthesia—Capecitabine—esophageal cancer	0.000941	0.000941	CcSEcCtD
Amphotericin B—Dyspnoea—Capecitabine—esophageal cancer	0.000934	0.000934	CcSEcCtD
Amphotericin B—Back pain—Methotrexate—esophageal cancer	0.000925	0.000925	CcSEcCtD
Amphotericin B—Dyspepsia—Capecitabine—esophageal cancer	0.000922	0.000922	CcSEcCtD
Amphotericin B—Decreased appetite—Capecitabine—esophageal cancer	0.000911	0.000911	CcSEcCtD
Amphotericin B—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000905	0.000905	CcSEcCtD
Amphotericin B—Vomiting—Cisplatin—esophageal cancer	0.000904	0.000904	CcSEcCtD
Amphotericin B—Rash—Cisplatin—esophageal cancer	0.000896	0.000896	CcSEcCtD
Amphotericin B—Pain—Capecitabine—esophageal cancer	0.000896	0.000896	CcSEcCtD
Amphotericin B—Constipation—Capecitabine—esophageal cancer	0.000896	0.000896	CcSEcCtD
Amphotericin B—Dermatitis—Cisplatin—esophageal cancer	0.000895	0.000895	CcSEcCtD
Amphotericin B—Ill-defined disorder—Methotrexate—esophageal cancer	0.000887	0.000887	CcSEcCtD
Amphotericin B—Anaemia—Methotrexate—esophageal cancer	0.000883	0.000883	CcSEcCtD
Amphotericin B—Feeling abnormal—Capecitabine—esophageal cancer	0.000864	0.000864	CcSEcCtD
Amphotericin B—Malaise—Methotrexate—esophageal cancer	0.000862	0.000862	CcSEcCtD
Amphotericin B—Vertigo—Methotrexate—esophageal cancer	0.000859	0.000859	CcSEcCtD
Amphotericin B—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000857	0.000857	CcSEcCtD
Amphotericin B—Leukopenia—Methotrexate—esophageal cancer	0.000856	0.000856	CcSEcCtD
Amphotericin B—Nausea—Cisplatin—esophageal cancer	0.000844	0.000844	CcSEcCtD
Amphotericin B—Cough—Methotrexate—esophageal cancer	0.000834	0.000834	CcSEcCtD
Amphotericin B—Urticaria—Capecitabine—esophageal cancer	0.000832	0.000832	CcSEcCtD
Amphotericin B—Abdominal pain—Capecitabine—esophageal cancer	0.000828	0.000828	CcSEcCtD
Amphotericin B—Body temperature increased—Capecitabine—esophageal cancer	0.000828	0.000828	CcSEcCtD
Amphotericin B—Convulsion—Methotrexate—esophageal cancer	0.000828	0.000828	CcSEcCtD
Amphotericin B—Myalgia—Methotrexate—esophageal cancer	0.000814	0.000814	CcSEcCtD
Amphotericin B—Chest pain—Methotrexate—esophageal cancer	0.000814	0.000814	CcSEcCtD
Amphotericin B—Arthralgia—Methotrexate—esophageal cancer	0.000814	0.000814	CcSEcCtD
Amphotericin B—Discomfort—Methotrexate—esophageal cancer	0.000804	0.000804	CcSEcCtD
Amphotericin B—Confusional state—Methotrexate—esophageal cancer	0.000787	0.000787	CcSEcCtD
Amphotericin B—Anaphylactic shock—Methotrexate—esophageal cancer	0.00078	0.00078	CcSEcCtD
Amphotericin B—Infection—Methotrexate—esophageal cancer	0.000775	0.000775	CcSEcCtD
Amphotericin B—Hypersensitivity—Capecitabine—esophageal cancer	0.000772	0.000772	CcSEcCtD
Amphotericin B—Thrombocytopenia—Methotrexate—esophageal cancer	0.000764	0.000764	CcSEcCtD
Amphotericin B—Skin disorder—Methotrexate—esophageal cancer	0.000758	0.000758	CcSEcCtD
Amphotericin B—Hyperhidrosis—Methotrexate—esophageal cancer	0.000754	0.000754	CcSEcCtD
Amphotericin B—Asthenia—Capecitabine—esophageal cancer	0.000752	0.000752	CcSEcCtD
Amphotericin B—Anorexia—Methotrexate—esophageal cancer	0.000744	0.000744	CcSEcCtD
Amphotericin B—Pruritus—Capecitabine—esophageal cancer	0.000741	0.000741	CcSEcCtD
Amphotericin B—Hypotension—Methotrexate—esophageal cancer	0.000729	0.000729	CcSEcCtD
Amphotericin B—Diarrhoea—Capecitabine—esophageal cancer	0.000717	0.000717	CcSEcCtD
Amphotericin B—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000711	0.000711	CcSEcCtD
Amphotericin B—Insomnia—Methotrexate—esophageal cancer	0.000706	0.000706	CcSEcCtD
Amphotericin B—Paraesthesia—Methotrexate—esophageal cancer	0.0007	0.0007	CcSEcCtD
Amphotericin B—Dyspnoea—Methotrexate—esophageal cancer	0.000695	0.000695	CcSEcCtD
Amphotericin B—Somnolence—Methotrexate—esophageal cancer	0.000693	0.000693	CcSEcCtD
Amphotericin B—Dizziness—Capecitabine—esophageal cancer	0.000693	0.000693	CcSEcCtD
Amphotericin B—Dyspepsia—Methotrexate—esophageal cancer	0.000687	0.000687	CcSEcCtD
Amphotericin B—Decreased appetite—Methotrexate—esophageal cancer	0.000678	0.000678	CcSEcCtD
Amphotericin B—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000673	0.000673	CcSEcCtD
Amphotericin B—Pain—Methotrexate—esophageal cancer	0.000667	0.000667	CcSEcCtD
Amphotericin B—Vomiting—Capecitabine—esophageal cancer	0.000666	0.000666	CcSEcCtD
Amphotericin B—Rash—Capecitabine—esophageal cancer	0.000661	0.000661	CcSEcCtD
Amphotericin B—Dermatitis—Capecitabine—esophageal cancer	0.00066	0.00066	CcSEcCtD
Amphotericin B—Headache—Capecitabine—esophageal cancer	0.000656	0.000656	CcSEcCtD
Amphotericin B—Feeling abnormal—Methotrexate—esophageal cancer	0.000643	0.000643	CcSEcCtD
Amphotericin B—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000638	0.000638	CcSEcCtD
Amphotericin B—Nausea—Capecitabine—esophageal cancer	0.000622	0.000622	CcSEcCtD
Amphotericin B—Urticaria—Methotrexate—esophageal cancer	0.00062	0.00062	CcSEcCtD
Amphotericin B—Abdominal pain—Methotrexate—esophageal cancer	0.000617	0.000617	CcSEcCtD
Amphotericin B—Body temperature increased—Methotrexate—esophageal cancer	0.000617	0.000617	CcSEcCtD
Amphotericin B—Hypersensitivity—Methotrexate—esophageal cancer	0.000575	0.000575	CcSEcCtD
Amphotericin B—Asthenia—Methotrexate—esophageal cancer	0.00056	0.00056	CcSEcCtD
Amphotericin B—Pruritus—Methotrexate—esophageal cancer	0.000552	0.000552	CcSEcCtD
Amphotericin B—Diarrhoea—Methotrexate—esophageal cancer	0.000534	0.000534	CcSEcCtD
Amphotericin B—Dizziness—Methotrexate—esophageal cancer	0.000516	0.000516	CcSEcCtD
Amphotericin B—Vomiting—Methotrexate—esophageal cancer	0.000496	0.000496	CcSEcCtD
Amphotericin B—Rash—Methotrexate—esophageal cancer	0.000492	0.000492	CcSEcCtD
Amphotericin B—Dermatitis—Methotrexate—esophageal cancer	0.000491	0.000491	CcSEcCtD
Amphotericin B—Headache—Methotrexate—esophageal cancer	0.000489	0.000489	CcSEcCtD
Amphotericin B—Nausea—Methotrexate—esophageal cancer	0.000463	0.000463	CcSEcCtD
